NASDAQ:XRAY

DENTSPLY SIRONA Stock Forecast, Price & News

$66.04

+0.64 (+0.98 %)

(As of 07/30/2021 12:00 AM ET)

Add

Compare

Today's Range

$65.15

▼

$66.54

50-Day Range

$60.69

▼

$67.65

52-Week Range

$41.52

▼

$69.54

Volume1.26 million shs

Average Volume1.06 million shs

Market Capitalization$14.42 billion

P/E Ratio83.59

Dividend Yield0.67%

Beta0.92

30 days | 90 days | 365 days | Advanced Chart

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
July 29, 2021 | finance.yahoo.com

Lancer Orthodontics (OTCMKTS:LANZ) & DENTSPLY SIRONA (NASDAQ:XRAY) Head-To-Head Review
July 28, 2021 | americanbankingnews.com

2 Great Growth Stocks in the Healthcare Sector
July 19, 2021 | stocknews.com

Traders Buy Large Volume of Call Options on DENTSPLY SIRONA (NASDAQ:XRAY)
July 13, 2021 | americanbankingnews.com

Hedge Funds Are Souring On DENTSPLY SIRONA Inc. (XRAY)
July 13, 2021 | finance.yahoo.com

Is There Now An Opportunity In DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
July 8, 2021 | nasdaq.com

Dental Space Gains Momentum in 2021: 4 Stocks to Invest in
July 8, 2021 | finance.yahoo.com

Return Trends At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Appealing
July 7, 2021 | finance.yahoo.com

DENTSPLY SIRONA to Host Second Quarter 2021 Conference Call on August 5th
July 6, 2021 | finance.yahoo.com

Analyzing Dentsply Sirona's Ex-Dividend Date
June 23, 2021 | benzinga.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:XRAY
Previous Symbol
CUSIP24903010
CIK818479
Webwww.dentsplysirona.com
Phone844-546-3722
Employees15,200
Year Founded2016

Sales & Book Value

Annual Sales$3.34 billion
Price / Sales4.31
Cash Flow$4.11 per share
Price / Cash Flow16.06
Book Value$22.74 per share
Price / Book2.90

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares218,320,000
Market Cap$14.42 billion
Next Earnings Date8/5/2021 (Confirmed)
OptionableOptionable

Social Links

MarketRank^™

Overall MarketRank^™

2.17 out of 5 stars

Medical Sector

175th out of 842 stocks

Dental Equipment & Supplies Industry

2nd out of 5 stocks

1.2 Analyst's Opinion

Consensus Rating
DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 4 buy ratings, 3 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $65.14, DENTSPLY SIRONA has a forecasted downside of 1.4% from its current price of $66.04.
Amount of Analyst Coverage
DENTSPLY SIRONA has only been the subject of 4 research reports in the past 90 days.

4.3 Community Rank

Outperform Votes
DENTSPLY SIRONA has received 418 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
DENTSPLY SIRONA has received 232 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
DENTSPLY SIRONA has received 64.31% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about DENTSPLY SIRONA and other stocks. Vote “Outperform” if you believe XRAY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
DENTSPLY SIRONA has a dividend yield of 0.67%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
DENTSPLY SIRONA has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of DENTSPLY SIRONA is 24.58%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 13.79% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DENTSPLY SIRONA insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,174,445.00 in company stock.
Percentage Held by Insiders
Only 0.69% of the stock of DENTSPLY SIRONA is held by insiders.
Percentage Held by Institutions
94.51% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for DENTSPLY SIRONA are expected to grow by 11.54% in the coming year, from $2.86 to $3.19 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of DENTSPLY SIRONA is 83.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 19.44.
Price to Earnings Ratio vs. Sector
The P/E ratio of DENTSPLY SIRONA is 83.59, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.55.
Price to Earnings Growth Ratio
DENTSPLY SIRONA has a PEG Ratio of 1.06. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
DENTSPLY SIRONA has a P/B Ratio of 2.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

Is DENTSPLY SIRONA a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DENTSPLY SIRONA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View analyst ratings for DENTSPLY SIRONA or view top-rated stocks.

What stocks does MarketBeat like better than DENTSPLY SIRONA?

Wall Street analysts have given DENTSPLY SIRONA a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DENTSPLY SIRONA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 2,100,000 shares, a decline of 34.0% from the June 15th total of 3,180,000 shares. Based on an average daily volume of 1,400,000 shares, the short-interest ratio is presently 1.5 days. Approximately 1.0% of the shares of the company are sold short.
View DENTSPLY SIRONA's Short Interest.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for DENTSPLY SIRONA.

How can I listen to DENTSPLY SIRONA's earnings call?

DENTSPLY SIRONA will be holding an earnings conference call on Thursday, August 5th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "4184820".

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) posted its earnings results on Thursday, May, 6th. The medical instruments supplier reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.17. The medical instruments supplier had revenue of $1.03 billion for the quarter, compared to analyst estimates of $944.89 million. DENTSPLY SIRONA had a net margin of 4.99% and a trailing twelve-month return on equity of 9.45%. The firm's revenue was up 17.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.43 EPS.
View DENTSPLY SIRONA's earnings history.

How has DENTSPLY SIRONA's stock price been impacted by Coronavirus (COVID-19)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XRAY shares have increased by 55.2% and is now trading at $66.04.
View which stocks have been most impacted by COVID-19.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Thursday, May 27th. Stockholders of record on Friday, June 25th will be given a dividend of $0.11 per share on Friday, July 9th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, June 24th. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.10.
View DENTSPLY SIRONA's dividend history.

Is DENTSPLY SIRONA a good dividend stock?

DENTSPLY SIRONA pays an annual dividend of $0.44 per share and currently has a dividend yield of 0.67%. DENTSPLY SIRONA does not yet have a strong track record of dividend growth. The dividend payout ratio of DENTSPLY SIRONA is 24.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 13.79% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
View DENTSPLY SIRONA's dividend history.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA updated its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share guidance of 2.750-2.900 for the period, compared to the Thomson Reuters consensus estimate of $2.730. The company issued revenue guidance of $4.10 billion-$4.30 billion, compared to the consensus revenue estimate of $4.14 billion.

What price target have analysts set for XRAY?

8 Wall Street analysts have issued 1-year price objectives for DENTSPLY SIRONA's shares. Their forecasts range from $47.00 to $78.00. On average, they expect DENTSPLY SIRONA's share price to reach $65.14 in the next twelve months. This suggests that the stock has a possible downside of 1.4%.
View analysts' price targets for DENTSPLY SIRONA or view top-rated stocks among Wall Street analysts.

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:

Mr. Donald M. Casey Jr., CEO & Director (Age 61, Pay $1.63M)
Mr. Jorge M. Gomez, Exec. VP & CFO (Age 53, Pay $1.42M)
Mr. Keith John Ebling, Exec. VP, Gen. Counsel & Sec. (Age 52, Pay $1.06M)
Ms. Lisa M. Yankie, Sr. VP and Chief HR Officer & Communications (Age 52, Pay $606.51k)
Mr. Walter Petersohn, Sr. VP & Chief Commercial Officer (Age 54, Pay $904.22k)
Mr. Ranjit S. Chadha, Chief Accounting Officer (Age 51)
Mr. Cord Friedrich Staehler, Sr. VP of Digital Platforms & Solutions and CTO (Age 51)
Andrea Daley, VP of Investor Relations
Mr. Chidam Alagappa Chidambaram, Sr. VP, Chief Marketing Officer & Chief Digital Officer (Age 54)
Dr. Albert J. Sterkenburg, Sr. VP (Age 57)

What is Don Casey's approval rating as DENTSPLY SIRONA's CEO?

105 employees have rated DENTSPLY SIRONA CEO Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among DENTSPLY SIRONA's employees.

Who are some of DENTSPLY SIRONA's key competitors?

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), Quidel (QDEL), STAAR Surgical (STAA), Neogen (NEOG), ICU Medical (ICUI), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Meridian Bioscience (VIVO), Cerus (CERS), OraSure Technologies (OSUR), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of XRAY's competitors.

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), The Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by many different institutional and retail investors. Top institutional shareholders include Alliancebernstein L.P. (0.13%), Kirr Marbach & Co. LLC IN (0.06%), State of Alaska Department of Revenue (0.05%), Cardinal Capital Management (0.04%), Clean Yield Group (0.03%) and Prentiss Smith & Co. Inc. (0.03%). Company insiders that own DENTSPLY SIRONA stock include Eric Brandt, Gregory T Lucier, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends for DENTSPLY SIRONA.

Which institutional investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Clean Yield Group, Alliancebernstein L.P., Bartlett & Co. LLC, LaFleur & Godfrey LLC, Raymond James Trust N.A., Sound Income Strategies LLC, and Sawyer & Company Inc. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Walter Petersohn, and Willie A Deese.
View insider buying and selling activity for DENTSPLY SIRONA or view top insider-selling stocks.

Which institutional investors are buying DENTSPLY SIRONA stock?

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Pflug Koory LLC, IFM Investors Pty Ltd, Livforsakringsbolaget Skandia Omsesidigt, Kirr Marbach & Co. LLC IN, First Command Bank, New Mexico Educational Retirement Board, Cardinal Capital Management, and Cutler Group LP.
View insider buying and selling activity for DENTSPLY SIRONA or or view top insider-buying stocks.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $66.04.

How much money does DENTSPLY SIRONA make?

DENTSPLY SIRONA has a market capitalization of $14.42 billion and generates $3.34 billion in revenue each year. The medical instruments supplier earns $-83,000,000.00 in net income (profit) each year or $1.79 on an earnings per share basis.

How many employees does DENTSPLY SIRONA have?

DENTSPLY SIRONA employs 15,200 workers across the globe.

When was DENTSPLY SIRONA founded?

DENTSPLY SIRONA was founded in 2016.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

Where are DENTSPLY SIRONA's headquarters?

DENTSPLY SIRONA is headquartered at 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]

This page was last updated on 7/31/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here